Detalhe da pesquisa
1.
Immune Regulatory Cell Bias Following Alemtuzumab Treatment in Relapsing-Remitting Multiple Sclerosis.
Front Immunol
; 12: 706278, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34777337
2.
Activation of the Protective Arm of the Renin Angiotensin System in Demyelinating Disease.
J Neuroimmune Pharmacol
; 15(2): 249-263, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31828731